TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
Maria Carmela Piccirillo, Paolo A. Ascierto, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Facciolongo, Fiorentino Fraganza, AnnaMaria Marata, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Roberto Parrella, Patrizia Popoli, Gerardo Botti, Laura Arenare, Paolo Chiodini, Ciro Gallo, Carlo Salvarani, Francesco Perrone
Topics & Concepts
MedicineTolerabilityCoronavirus disease 2019 (COVID-19)TocilizumabPneumoniaMulticenter study2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineVirologyAdverse effectRandomized controlled trialInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchDiverse Scientific Research Studies